A Clinical Approach to Managing Toxic Exposure Effects

Understand the critical aspects of a clinical approach to toxic exposure and its role in public health and safety.

Abstract

In this comprehensive educational post, I will guide you through the complex world of toxicological emergencies from an integrative medicine perspective. As a Doctor of Chiropractic, Advanced Practice Registered Nurse, and a Board-Certified Family Nurse Practitioner with extensive training in functional medicine, I bring a unique, multifaceted viewpoint to patient care. This post is designed for both healthcare professionals and individuals seeking to understand the profound impact of common and uncommon toxins on the human body. We will journey through the latest evidence-based research from leading experts, exploring the physiological mechanisms behind various toxidromes—from anticholinergic and cholinergic crises to sympathomimetic overdoses, cardiotoxic emergencies, and insidious ingestions like toxic alcohols and salicylates. I will detail the diagnostic processes, initial management strategies like decontamination and advanced airway decisions, and the specific antidotes and reversal agents used in modern clinical practice, including high-dose naloxone, high-dose insulin euglycemic therapy (HIET), intravenous lipid emulsion (ILE) therapy, fomepizole, and N-acetylcysteine.

Furthermore, I will explain how our unique multidisciplinary practice at Injury Medical Clinic PA in El Paso, Texas, integrates chiropractic care, under my direction, with the invaluable medical oversight of our Medical Director, Dr. Maria Guadalupe Cardenas, an internist with over 40 years of experience. We will explore how this collaborative model enhances patient recovery, particularly in the context of personal injury and the long-term sequelae of toxic exposures, by addressing the structural, neurological, and metabolic dysfunctions that arise. From emergent stabilization to long-term recovery, this post will illuminate how an integrative and scientifically rigorous perspective provides a comprehensive safety net for our patients.

Our Integrative Care Model: A Synergy of Chiropractic and Internal Medicine

Before we delve into the specifics of toxicology, I believe it is crucial to provide a clear understanding of our clinical philosophy and practice structure here at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas. Our approach is fundamentally integrative and multidisciplinary, a model that I have found to be exceptionally effective in treating the whole person, not just a collection of symptoms.

I am Dr. Alex Jimenez, and my journey in healthcare has led me to accumulate a diverse set of credentials: Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), a Board-Certified Family Nurse Practitioner (FNP-BC), a Certified Functional Medicine Practitioner (CFMP) from two separate prestigious institutions (IFMCP and CFMP), and certifications in anti-aging medicine (ATN) and chiropractic clinical science and technology (CCST). This broad educational foundation, reflected in my work at WellnessDoctorRx and my professional profile on LinkedIn, allows me to view patient health through multiple lenses—structural, neurological, metabolic, and cellular.

Our collaboration with Dr. Maria Guadalupe Cardenas, MD, profoundly strengthens our practice. Dr. Cardenas is a highly respected physician, board-certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933), and brings over four decades of clinical wisdom to our team. She serves as our Medical Director and Collaborative Physician, a role that is integral to our ability to provide comprehensive, safe, and effective care. This type of MD-DC collaboration is a cornerstone of modern integrative and injury care clinics, ensuring that patients receive the benefits of both medical and chiropractic expertise under one roof.

The Collaborative Framework

Our team-based model works as follows:

• Medical Oversight (Dr. Cardenas): Dr. Cardenas provides the essential medical direction for our clinic. She reviews complex cases, oversees medical protocols, and is available for consultation, ensuring that all treatments meet the highest standards of medical care. Her role is particularly vital when patients present with conditions that have both musculoskeletal and systemic components, such as those following a toxic exposure or a significant personal injury. She can prescribe medications when necessary, order advanced diagnostic imaging and laboratory tests, and manage comorbidities that might impact a patient’s recovery.
• Chiropractic and Functional Medicine (Dr. Jimenez): I lead the clinical application of chiropractic care, functional medicine, rehabilitation, and personal injury protocols. My focus is on identifying and addressing the root causes of dysfunction.

• Chiropractic Care: This involves specific spinal and extremity adjustments to restore proper joint mechanics, alleviate nerve interference, and improve overall nervous system function. The nervous system is the master controller of the body, and ensuring its optimal function is paramount, especially when the body is under the stress of a toxic burden or physical trauma.
• Functional Medicine: We use this patient-centered approach to understand the “why” behind a patient’s illness. Through detailed history-taking and advanced laboratory testing (e.g., assessing gut health, nutrient status, inflammatory markers, and detoxification pathways), we create personalized treatment plans that may include nutritional therapy, targeted supplementation, and lifestyle modifications to support the body’s innate healing capabilities.
• Rehabilitation & Personal Injury Care: For patients recovering from injuries, we design comprehensive rehabilitation programs that integrate therapeutic exercises, soft tissue therapies, and advanced modalities to restore strength, flexibility, and function, facilitating a faster and more complete recovery.

By integrating these disciplines, we create a synergistic effect. A patient recovering from a toxic exposure, for instance, may benefit from Dr. Cardenas’s medical management of acute symptoms and organ support. At the same time, my functional medicine approach addresses the underlying detoxification pathways and nutritional deficiencies. Simultaneously, chiropractic adjustments can help regulate the autonomic nervous system, which is often thrown into disarray by toxins, thereby aiding in the restoration of homeostasis. This comprehensive strategy allows us to support patients from the acute phase of an illness through their long-term recovery and wellness journey.

Now, let’s transition to the core topic of this educational post: understanding and managing toxicological emergencies.

Foundations of Toxicological Management

When a patient presents to a clinical setting after a potential toxic exposure, a systematic and prioritized approach is essential. While the specifics of treatment will vary greatly depending on the substance involved, the foundational principles of patient assessment and initial management remain constant. Our primary goal is always to stabilize the patient and prevent further harm.

Why Airway Decisions Define Outcomes: The ABCs in Toxicology

I always begin with the ABCs (Airway, Breathing, Circulation). Toxicology emergencies often feature altered consciousness, respiratory instability, or hemodynamic shifts that can deteriorate rapidly. The physiological basis is crucial:

• A: Airway: Is the airway open and clear? Is the patient able to protect their own airway, or are they at risk of obstruction from a relaxed tongue, secretions, or vomit? Obstruction risk from depressed mental status or neuromuscular dysfunction is high, and the aspiration risk rises with interventions like charcoal or emesis.
• B: Breathing: Is the patient breathing adequately? What is their respiratory rate and effort? Are their breath sounds clear? Pulse oximetry is a vital tool here. A key consideration is compensatory hyperventilation, especially in metabolic acidosis (e.g., salicylate poisoning, DKA)—a life-preserving mechanism that stabilizes pH by lowering PaCO2 through respiratory alkalosis.
• C: Circulation: What is the patient’s heart rate, blood pressure, and perfusion status (e.g., skin color, temperature, capillary refill)? An intravenous (IV) line should be established promptly for fluid and medication administration. Circulation can be compromised by hypotension from vasodilation or cardiotoxic effects, hypertension and tachycardia from sympathomimetics, or volume challenges in coagulopathy management.

Beyond the ABCs, two other immediate steps are crucial in any patient with an altered mental status:

1. Check a Blood Glucose: Hypoglycemia (low blood sugar) is a common and easily reversible cause of altered mental status. Furthermore, some toxins can induce hypoglycemia by either increasing insulin release or impairing the body’s ability to produce glucose. A rapid finger-stick glucose test is mandatory.
2. The “One Drug to Rule Them All”: If I had to choose only one initial medication to have on hand for a wide range of toxicological emergencies, it would be a benzodiazepine, such as midazolam or lorazepam. These medications are invaluable for managing the “hyper” states associated with many toxidromes. They are the first-line treatment for agitation, psychosis, seizures, and toxin-induced hyperthermia, hypertension, and tachycardia.

Decontamination: The First Line of Defense

The very first consideration, often before the patient even enters the main treatment area, is decontamination. This is a critical step, not only for the patient’s well-being but also for the safety of the healthcare team and the facility. The route of exposure dictates the method of decontamination.

• Dermal (Skin) Exposure: Many chemicals can be readily absorbed through the skin. If a patient arrives covered in a substance, immediate removal of contaminated clothing and thorough washing of the skin with copious irrigation with water is paramount. It is important to remember that there are exceptions. For example, certain dry chemicals like lime react with water to produce heat, causing thermal burns. In such cases, the chemical should be brushed off completely before any water is applied.
• Inhalation Exposure: If the exposure was through inhalation of a gas, vapor, or aerosol, the immediate priority is to move the patient to a source of fresh air, away from the contaminated environment. Supplemental oxygen is often administered.
• Gastrointestinal (GI) Decontamination: For ingested toxins, the approach to decontamination has evolved significantly.

• Induction of Emesis (Vomiting): This practice is no longer recommended due to limited benefit and a high risk of aspiration.
• Gastric Lavage (“Stomach Pumping” ): Similar to induced emesis, gastric lavage is now rarely performed. Its efficacy is highly time-dependent (within one hour of ingestion) and carries risks of injury and aspiration.
• Activated Charcoal: This remains a useful tool. It works by adsorption, binding many drugs and toxins in the GI tract to prevent their absorption. Its effectiveness is greatest when given within the first one to two hours of ingestion. A critical prerequisite is ensuring the patient has a protected airway. In lethargic or compromised patients, we secure the airway before administration to prevent aspiration. It’s also important to know which substances are not effectively bound by charcoal, such as alcohols, iron, lithium, heavy metals, and caustics.
• Whole Bowel Irrigation (WBI): This method involves administering large volumes of a polyethylene glycol (PEG) electrolyte solution to flush the entire GI tract. WBI is considered for ingestions of substances not amenable to charcoal (like iron or lithium), long-acting formulations, or for “body packers”. It accelerates transit, resulting in copious diarrhea; we monitor electrolytes and hydration carefully.

With these foundational principles in mind, we can now explore the specific patterns of signs and symptoms, known as toxidromes, that help us identify the class of toxin involved.

Unraveling the Anticholinergic Toxidrome: “Hot as a Hare, Blind as a Bat”

Let’s begin with a clinical scenario. Imagine you are evaluating a 2-year-old child brought in by paramedics for an unknown ingestion and seizure activity. The child’s vital signs are: heart rate 190 beats/minute, respiratory rate 30 breaths/minute, blood pressure 110/65 mmHg, and a temperature of 103.1°F (39.5°C). On physical examination, you note that the pupils are widely dilated (mydriasis) and non-reactive to light. The child’s skin is flushed, feels very hot, and is strikingly dry.

Identifying the Pattern

This constellation of findings—tachycardia, hyperthermia, mydriasis, and dry, flushed skin, combined with an altered mental status—is the classic presentation of the anticholinergic toxidrome. The well-known mnemonic captures these features perfectly:

• “Hot as a hare” (Hyperthermia)
• “Blind as a bat” (Mydriasis, causing blurred vision)
• “Dry as a bone” (Dry skin and mucous membranes, due to decreased secretions)
• “Red as a beet” (Flushed skin, due to peripheral vasodilation)
• “Mad as a hatter” (Altered mental status, ranging from agitation and confusion to delirium and hallucinations)

Additionally, these patients often experience urinary retention and decreased bowel sounds.

The Physiology of Acetylcholine Blockade

To understand this toxidrome, we must understand the role of the neurotransmitter acetylcholine (ACh) in the parasympathetic nervous system—the “rest and digest” system. Anticholinergic substances work by competitively blocking muscarinic receptors, preventing ACh from binding. The result is an unopposed sympathetic (“fight or flight”) tone, leading to the signs and symptoms we observe:

• Heart: Blockade of ACh at the heart’s pacemaker results in tachycardia.
• Glands: Blockade of receptors on sweat, salivary, and bronchial glands leads to dry skin, dry mouth, and thickened bronchial mucus. The inability to sweat is a major contributor to the dangerous hyperthermia.
• Eyes: Blockade of receptors in the iris and ciliary muscle leads to mydriasis (pupil dilation) and cycloplegia (paralysis of accommodation), causing blurred vision.
• Central Nervous System (CNS): Anticholinergics that can cross the blood-brain barrier block ACh receptors in the brain, leading to the characteristic altered mental status.

A Critical Finding: The ECG and Sodium Channel Blockade

In any tachycardic patient with a suspected toxic ingestion, obtaining a 12-lead ECG is a critical and urgent step. Let’s say the ECG for this child shows a sinus tachycardia, but more importantly, the QRS complex is wide, measuring over 100 milliseconds.

This wide QRS is a highly ominous sign. It indicates a sodium channel blockade. Certain drugs, most notably the tricyclic antidepressants (TCAs) like amitriptyline, not only have potent anticholinergic effects but also block the fast sodium channels in the heart. When these sodium channels are blocked, cardiac depolarization slows down, widening the QRS complex. This can lead to life-threatening ventricular arrhythmias. Another key ECG finding in TCA toxicity is a prominent R wave in lead aVR.

Common Culprits of Anticholinergic Toxicity

• Tricyclic Antidepressants (TCAs)
• Antihistamines (e.g., diphenhydramine)
• Antipsychotics
• Muscle Relaxants (e.g., cyclobenzaprine)
• Overactive Bladder Medications (e.g., oxybutynin)
• Antiparkinsonian Agents (e.g., benztropine)
• Plants (e.g., Jimsonweed, Deadly Nightshade)

Management Strategy for Anticholinergic Toxicity

1. Supportive Care (The ABCs): Secure the airway if needed, provide oxygen, and administer IV fluids for hypotension. If fluids are insufficient, a vasopressor like norepinephrine is the agent of choice.
2. Seizure Control: Benzodiazepines are the first-line treatment.
3. Hyperthermia Management: Aggressive external cooling is essential.
4. GI Decontamination: Activated charcoal can be given if the patient presents within 1-2 hours of ingestion and has a protected airway.
5. Targeted Therapy: Sodium Bicarbonate for Sodium Channel Blockade: This is the cornerstone of treatment for TCA toxicity. A bolus of sodium bicarbonate (1-2 mEq/kg) is administered, followed by a continuous infusion. It works by increasing systemic pH (alkalization), which pulls the TCA off the sodium channels, and by providing a large sodium load to overpower the channel blockade.
6. The Antidote: Physostigmine (Use with Extreme Caution): The specific antidote is physostigmine, an acetylcholinesterase inhibitor. It increases the amount of ACh available to overcome the blockade. However, its use is absolutely contraindicated if there is any evidence of a wide QRS on the ECG, as it can precipitate life-threatening bradycardia and asystole in TCA toxicity. Its use should be restricted to cases of pure anticholinergic toxicity (e.g., from diphenhydramine) with severe delirium refractory to benzodiazepines, and only after consultation with a toxicologist.

The Cholinergic Crisis: “Sludge and the Killer B’s”

Now, let’s pivot to the opposite end of the spectrum. You are called to evaluate a farmworker who was found collapsed in a field after spraying pesticides without protective gear. The patient is sweating profusely, vomiting, and has pinpoint pupils (miosis). He is struggling to breathe with audible gurgling sounds. Vital signs are: heart rate 45, blood pressure 90/50, and respiratory rate 12.

Identifying the Pattern and the Physiology

This is a cholinergic crisis, caused by an excess of acetylcholine, most classically from organophosphate pesticides. These substances work by inhibiting acetylcholinesterase, the enzyme that breaks down ACh. The resulting accumulation of ACh leads to massive overstimulation of both muscarinic and nicotinic cholinergic receptors.

Two mnemonics memorably summarize the effects:

1. Muscarinic Effects (“SLUDGEM” or “DUMBBELS” ):

• • Salivation, Lacrimation, Urination, Defecation, GI cramping, Emesis, M

The most life-threatening muscarinic effects are the”Killer B’s”:

• Bronchorrhea (massive outpouring of fluid into the airways)
• Bronchospasm (constriction of the airways)
• Bradycardia (severe slowing of the heart rate)

The combination of bronchorrhea and bronchospasm leads to rapid respiratory failure; the patient literally drowns in their own secretions.

2. Nicotinic Effects (“Days of the Week” ):

• • Mydriasis / Muscle cramps, Tachycardia, Weakness, Hypertension, Fasciculations (progressing to paralysis).

The most dangerous nicotinic effect is paralysis, particularly of the diaphragm, which, combined with the”Killer B’s,” creates a perfect storm for respiratory arrest.

Management Strategy for Cholinergic Crisis

1. Decontamination and Provider Safety: This is paramount. The patient must be fully decontaminated before being brought into the main treatment area. All healthcare providers must wear appropriate personal protective equipment (PPE).
2. Airway and Breathing: This is the absolute priority. The patient will likely require immediate endotracheal intubation and aggressive suctioning to clear the massive volume of secretions.
3. Antidotal Therapy: Two key antidotes must be administered concurrently.

• • Atropine: This is a competitive antagonist at muscarinic receptors. It directly counteracts the “SLUDGEM” and “Killer B” effects. The goal of atropine therapy is to dry up the bronchial secretions. Large, heroic doses are often required. An initial dose of 2-5 mg IV is given and doubled every 2-5 minutes until the lungs are clear. There is no maximum dose.
  • Pralidoxime (2-PAM): While atropine blocks the effects of excess ACh, pralidoxime fixes the underlying problem by “reactivating” the acetylcholinesterase enzyme. It is critical to administer 2-PAM as soon as possible. Over time, the bond between the organophosphate and the enzyme undergoes “aging,” becoming permanent and irreversible.

• Seizure Control: Benzodiazepines are the treatment of choice.

Navigating the Sympathomimetic Toxidrome: The Storm of “Fight or Flight”

Let’s consider another case. A 25-year-old male is brought to the emergency department after a party. He is extremely agitated, paranoid, and complaining of chest pain. He admits he may have used cocaine. His vital signs are: heart rate 140, blood pressure 190/110, temperature 102.5°F (39.2°C). His pupils are dilated, and his skin is profusely sweaty (diaphoretic).

Identifying the Pattern and the Physiology

This is the classic sympathomimetic toxidrome, caused by an overdose of stimulant drugs like cocaine, amphetamines, “bath salts,” and MDMA. These drugs block the reuptake of catecholamines—norepinephrine, dopamine, and serotonin—leading to intense and prolonged stimulation of adrenergic receptors.

The clinical presentation is one of global overstimulation, summarized by the mnemonic MASS:

• Mydriasis
• Agitation, Arrhythmias, Angina
• Seizures, Sweating
• Severe hypertension and tachycardia

The key difference that helps distinguish a sympathomimetic toxidrome from an anticholinergic one is the skin. Anticholinergic patients are hot and dry. Sympathomimetic patients are hot and wet (diaphoretic).

The Dangers of the Sympathetic Storm

The profound cardiovascular stimulation can lead to devastating consequences like myocardial infarction (MI), aortic dissection, arrhythmias, rhabdomyolysis, and severe hyperthermia.

Management Strategy for Sympathomimetic Toxicity

1. Benzodiazepines, Benzodiazepines, Benzodiazepines! This cannot be overemphasized. Benzodiazepines are the first, second, and third-line treatment for sympathomimetic toxicity, treating agitation, seizures, tachycardia, hypertension, and hyperthermia.
2. Cooling: For patients with hyperthermia, aggressive external cooling measures are critical.
3. Managing Refractory Hypertension: The Beta-Blocker Controversy: The traditional teaching has been to avoid pure beta-blockers due to the theory of “unopposed alpha-stimulation,” which could paradoxically worsen hypertension. The most prudent approach remains to first use benzodiazepines. If a second agent is needed, a direct-acting vasodilator like nitroglycerin or a mixed alpha/beta-blocker like labetalol is preferred.
4. Managing Cocaine-Induced Chest Pain: Treat with aspirin, nitroglycerin, and benzodiazepines. If there is evidence of sodium channel blockade (wide QRS), sodium bicarbonate should be administered. Avoid pure beta-blockers.
5. Supportive Care: Provide IV fluids to maintain urine output and help prevent rhabdomyolysis-induced kidney injury.

The Opioid Toxidrome: A Crisis of Respiratory Depression

Let’s turn to a tragically common scenario. Paramedics bring in an 18-year-old male who was found unresponsive. On exam, he is comatose, with a respiratory rate of only 4 breaths per minute and pinpoint pupils.

Identifying the Classic Triad

This presentation is the hallmark of the opioid toxidrome. The classic triad of signs includes:

1. Central Nervous System (CNS) Depression: Ranging from lethargy to profound coma.
2. Respiratory Depression: This is the most life-threatening feature, leading to hypoxia, hypercarbia, and ultimately respiratory arrest.
3. Miosis: Pinpoint pupils.

The Physiology of Opioid Action

Opioids—including heroin, fentanyl, and oxycodone—bind to mu-opioid receptors. In the brainstem respiratory centers, this binding profoundly suppresses the brain’s responsiveness to carbon dioxide, the primary driver of our impulse to breathe. The patient “forgets” to breathe. The increasing prevalence of highly potent synthetic opioids like fentanyl has made this toxidrome even more deadly.

Management: The Power of Naloxone

1. Airway and Breathing: The immediate priority is to support the patient’s breathing, typically with a bag-valve-mask (BVM) device.
2. The Antidote: Naloxone (Narcan®): Naloxone is a pure, competitive opioid antagonist. It displaces opioids from the mu-receptor, rapidly reversing their effects.

• • Dosing and Titration: The goal of naloxone administration is not to fully wake the patient up, but to restore adequate spontaneous respirations. A typical starting dose is 0.4 mg. Administering too much too quickly can precipitate a severe acute withdrawal syndrome. Therefore, the best practice is to titrate to effect.
  • Half-Life Mismatch: Naloxone has a relatively short half-life (60-90 minutes) compared to many opioids. This creates a risk of resedation. All patients who receive naloxone require a prolonged period of observation.
  • High-Dose Naloxone for Synthetic Opioids: The extreme potency of fentanyl and its analogs often means that standard doses are insufficient. It is not uncommon to require massive doses of naloxone—sometimes 10 mg or more.

Sedative-Hypnotic Toxidrome: A Spectrum of CNS Depression

This toxidrome, caused by drugs like benzodiazepines and barbiturates, shares features with the opioid toxidrome but with important distinctions.

Identifying the Pattern and Physiology

Like opioids, these drugs cause CNS and respiratory depression. However, pupils are typically mid-sized or normal. These drugs work by enhancing the effect of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA).

Management and the Antidote for Benzodiazepines

1. Supportive Care: The mainstay of treatment is meticulous supportive care. This involves protecting the airway and supporting breathing and circulation.
2. The Antidote: Flumazenil (Use with Extreme Caution): For benzodiazepine overdoses, flumazenil is a specific antidote. However, it is rarely used because it can precipitate intractable seizures in chronic benzodiazepine users or in a polysubstance overdose involving a pro-convulsant drug (like a TCA). Its use is generally contraindicated in the setting of an unknown overdose.

There is no specific antidote for barbiturate overdose; treatment is purely supportive.

The Silent Overdose: Clonidine and Xylazine Toxicity

Let’s start with a scenario that requires sharp diagnostic skills. A five-year-old child is profoundly lethargic, with bradycardia, hypotension, and miosis. This presentation mimics an opioid overdose. However, the parents report the child is on medication for ADHD. This makes clonidine a prime suspect.

Understanding Clonidine: A Central Alpha-2 Agonist

Clonidine is a central alpha-2 adrenergic agonist. It works by stimulating presynaptic alpha-2 receptors in the brainstem, which function as a negative feedback loop. This activation tricks the brain into thinking there is an excess of sympathetic outflow, leading to a marked decrease in norepinephrine release. The result is a classic triad of symptoms in overdose: hypotension, bradycardia, and CNS depression, along with miosis, closely mimicking the opioid toxidrome.

The Treatment Plan: Why Naloxone?

Given the clinical presentation, which strongly resembles an opioid ingestion, the immediate treatment plan, perhaps surprisingly, is naloxone. While the exact mechanism is debated, naloxone can be effective in reversing the CNS and respiratory depression caused by clonidine. The prevailing theory is that clonidine’s action may trigger the release of endogenous opioids, which are then blocked by naloxone.

For non-opioid overdoses like clonidine, the recommendation is often to go high with the naloxone dose, sometimes up to 10 milligrams, as there is no risk of precipitating withdrawal. The mnemonic ROCK LOTA X is a useful tool for remembering other substances, besides opioids, that may be reversed with naloxone: Reserpine, Opioids, Clonidine, Lomotil, Other opioids, Tizanidine, ACE Inhibitors, and Xylazine.

The Rise of “Tranq”: Understanding Xylazine Toxicity

A discussion of central alpha-2 agonists would be incomplete without addressing xylazine, a veterinary tranquilizer increasingly found as an adulterant in illicit drugs, particularly fentanyl. It is known by street names like “tranq” or the “zombie drug.”

Xylazine is pharmacologically similar to clonidine. Its dangers include:

1. Profound Sedation and Respiratory Depression: When combined with fentanyl, the result is a synergistic and often lethal overdose.
2. Naloxone Resistance (Partial): Because xylazine is not an opioid, the respiratory depression it causes does not fully respond to naloxone. Naloxone will reverse the fentanyl component, but the patient may remain sedated and with some respiratory depression due to the xylazine.
3. Severe Tissue Necrosis: When injected, xylazine causes severe vasoconstriction, leading to profound tissue hypoxia and the development of large, open, ulcerating wounds that are notoriously difficult to heal. This horrific property is why it has earned the moniker “zombie drug.”

The Hidden Dangers of Over-the-Counter Medications

Two of the most common and dangerous overdoses involve medications available without a prescription: acetaminophen and aspirin.

Acetaminophen (Tylenol®) Toxicity: The Silent Liver Killer

In overdose, acetaminophen is a leading cause of acute liver failure. The parent drug does not cause the toxicity, but it is produced by a highly reactive metabolite, N-acetyl-p-benzoquinone imine (NAPQI). In an overdose, the liver’s stores of glutathione, which normally detoxify NAPQI, are depleted. Free NAPQI then binds to liver cells, causing necrosis.

The Four-Hour Level and the Rumack-Matthew Nomogram

The cornerstone of risk assessment in acute acetaminophen ingestion is the serum acetaminophen level drawn at 4 hours or more post-ingestion. This level is plotted on the Rumack-Matthew Nomogram. If the level falls above the “treatment line,” the patient is at risk for hepatotoxicity, and treatment is initiated.

Management and the Antidote: N-Acetylcysteine (NAC)

The life-saving antidote for APAP poisoning is N-acetylcysteine (NAC). It is nearly 100% effective in preventing hepatotoxicity if started within 8 hours of ingestion. NAC works by serving as a glutathione precursor, helping to replenish the liver’s depleted stores, and by directly substituting for glutathione in detoxifying NAPQI.

Salicylate (Aspirin) Toxicity: A Complex Metabolic Derangement

Salicylate toxicity is complex because it disrupts multiple metabolic processes, most notably cellular respiration.

Signs, Symptoms, and Physiology

• Mechanism: Salicylates uncouple oxidative phosphorylation in the mitochondria. This process dissipates energy as heat instead of capturing it as ATP.
• Clinical Effects:

• Initial Respiratory Alkalosis: Salicylates directly stimulate the respiratory center, causing hyperventilation.
• Later Metabolic Acidosis: As poisoning progresses, a buildup of organic acids results in a severe, high-anion-gap metabolic acidosis. The classic acid-base disturbance is a mixed respiratory alkalosis and metabolic acidosis.
• Other Symptoms: Tinnitus, nausea, vomiting, diaphoresis, hyperthermia, and altered mental status are common.

One clinical observation I stress in my practice is that tinnitus plus hyperventilation should never be dismissed as anxiety—consider salicylates until ruled out.

Management: Alkalinization and Enhanced Elimination

Management focuses on supportive care and enhancing elimination.

1. Urinary Alkalinization: This is a cornerstone of treatment. A sodium bicarbonate infusion is given to raise the urine pH to 7.5-8.0. In an alkaline urine, salicylates become ionized (“trapped”) and cannot be reabsorbed, dramatically enhancing their renal excretion.
2. Hemodialysis: This is the definitive treatment for severe salicylate poisoning, rapidly removing salicylates from the blood and correcting severe acidosis.

A critical principle: when patients present with profound hyperventilation due to metabolic acidosis from salicylates, intubation requires precise matching of pre-intubation ventilation. Dropping the respiratory rate will allow CO2 to rise, potentially precipitating abrupt acidemia, arrhythmias, and cardiac arrest.

Unmasking the Silent Threat: Understanding Cyanide and Carbon Monoxide Poisoning

Inhalation injuries, particularly from structure fires, present unique toxicological challenges.

Cyanide Poisoning

Cyanide is a rapidly lethal cellular asphyxiant. It is a major cause of death in structure fires, alongside carbon monoxide.

• Mechanism: Cyanide inhibits cytochrome c oxidase (complex IV) in the mitochondrial electron transport chain. This completely halts aerobic metabolism, forcing cells into anaerobic metabolism. The result is a massive and rapid production of lactic acid, leading to profound metabolic acidosis and cellular hypoxia. The tragic irony is that the patient’s blood is often saturated with oxygen, but the cells are completely unable to use it.
• Clinical Picture: Patients present with altered mental status, seizures, and severe acidosis with Kussmaul’s respirations. If a patient from a fire is comatose and acidotic, cyanide poisoning must be strongly suspected.
• Treatment: Hydroxocobalamin: The modern antidote is hydroxocobalamin (Cyanokit). It contains a cobalt ion that directly binds to cyanide, forming cyanocobalamin (vitamin B12), a non-toxic compound that is safely excreted by the kidneys. This treatment is elegant and effective, directly chelating the toxin without interfering with the blood’s oxygen-carrying capacity.

Carbon Monoxide (CO) Poisoning

CO is an insidious poison because it is colorless, odorless, and tasteless. A high index of suspicion is essential, especially during colder months.

• The Deceptive Blood Gas: Standard pulse oximeters and ABG analyses can be profoundly misleading. A standard pulse oximeter cannot distinguish between carboxyhemoglobin (CO-bound hemoglobin) and oxyhemoglobin, leading to a falsely high SpO2 reading. The PaO2, which measures dissolved oxygen, will also be normal. The definitive diagnostic test is a CO-oximetry analysis to measure the carboxyhemoglobin (COHb) level.
• Mechanism: CO binds to hemoglobin approximately 200 to 250 times more tightly than oxygen. This competitively displaces oxygen and also causes a “left shift” of the oxyhemoglobin dissociation curve, meaning the hemoglobin that is still carrying oxygen doesn’t release it effectively to the tissues.
• Treatment: Oxygen. Administering 100% oxygen via a non-rebreather mask drastically shortens the half-life of carboxyhemoglobin from 4-5 hours on room air to about 60-90 minutes. For severe cases, Hyperbaric Oxygen Therapy (HBOT) may be considered, which further reduces the half-life to 20-30 minutes.

The Hidden Dangers: Toxic Alcohols and the Anion Gap

Case 1: A patient presents with refractory seizures and a profound anion gap metabolic acidosis. This is highly suggestive of ethylene glycol ingestion.

Case 2: Treatment for a methanol or ethylene glycol ingestion may include ethanol or, more commonly today, fomepizole.

The Anion and Osmolar Gaps: Critical Calculations

In any patient with metabolic acidosis, calculating the anion gap is essential. The formula is Anion Gap = [Na+] – ([Cl-] + [HCO3-]). A high anion gap (e.g., >16) signifies an excess of an unmeasured acid, a red flag for a toxic ingestion. The mnemonic CAT MUDPILES helps remember common causes.

When you suspect a toxic alcohol, the next step is to calculate the osmolar gap: Osmolar Gap = Measured Osmolality – Calculated Osmolality. An elevated osmolar gap suggests the presence of an osmotically active substance like an alcohol. An elevated osmolar gap plus a high anion gap is highly suggestive of a toxic alcohol ingestion (methanol or ethylene glycol).

The Toxic Alcohols: It’s the Metabolites That Kill

The parent compounds methanol and ethylene glycol are not particularly toxic. The danger lies in what our bodies metabolize them into via the enzyme alcohol dehydrogenase (ADH).

1. Ethylene Glycol (Antifreeze): Metabolized to glycolic acid (causing acidosis) and oxalic acid. Oxalic acid forms calcium oxalate crystals that deposit in the renal tubules, causing acute kidney failure, and in the brain, causing seizures.
2. Methanol (Windshield Wiper Fluid): Metabolized to formaldehyde and then formic acid. Formic acid is extremely toxic, inhibiting cellular respiration and having a particular affinity for the optic nerve, causing the classic and often irreversible blindness (“snowstorm vision”).
3. Isopropyl Alcohol (Rubbing Alcohol): Metabolized to acetone, which causes intoxication and an elevated osmolar gap but does not cause a metabolic acidosis.

Treatment: Blocking the Pathway

The entire treatment strategy is based on stopping the metabolism of the parent alcohol by blocking ADH.

1. Fomepizole (Antizol): This is the modern, FDA-approved antidote. Fomepizole is a potent competitive inhibitor of ADH, preventing the formation of toxic metabolites.
2. Ethanol (Competitive Inhibition): Before fomepizole, ethanol was the treatment of choice. ADH has a much higher affinity for ethanol, so saturating the enzyme with ethanol competitively inhibits the metabolism of toxic alcohols.
3. Hemodialysis: This is the ultimate treatment for severe toxic alcohol poisoning, effectively removing both the parent alcohol and its toxic metabolites.

Advanced Therapies for Cardiotoxic Emergencies

Let’s shift to a new clinical scenario. A 60-year-old individual presents with profound hypotension and severe bradycardia. Their medication list includes metoprolol (a beta-blocker) and diltiazem (a calcium channel blocker). An overdose of either is a life-threatening emergency. A finger-stick blood glucose can help differentiate:

• Beta-Blocker Overdose → Hypoglycemia: Beta-blockers interfere with glycogenolysis.
• Calcium Channel Blocker Overdose → Hyperglycemia: CCBs block insulin release from the pancreas, which is a calcium-dependent process.

When standard resuscitation fails, we escalate to advanced therapies.

High-Dose Insulin Euglycemic Therapy (HIET)

HIET has emerged as a revolutionary treatment for severe cardiotoxicity caused by beta-blocker and calcium channel blocker (CCB) overdoses.

• The “Starving Heart” Concept: In profound shock, the heart is forced to use glucose for energy, but CCB/beta-blocker toxicity impairs its ability to do so. The heart is literally starving for energy.
• How Insulin Helps: High-dose insulin acts as a powerful inotrope. It facilitates glucose uptake into cardiac cells, providing the necessary substrate for energy production and improving cardiac contractility.
• The HIET Protocol: The protocol involves a bolus of regular insulin (1 unit/kg) followed by a continuous infusion of 1-10 units/kg/hour. A simultaneous dextrose infusion is essential to maintain euglycemia (normal blood sugar), with frequent glucose monitoring.

Intravenous Lipid Emulsion (ILE) Therapy

Also known as “lipid rescue,” ILE therapy is another cutting-edge treatment, particularly for local anesthetic systemic toxicity (LAST) and overdoses of other highly lipophilic (fat-soluble) drugs like TCAs, beta-blockers, and CCBs.

• The “Lipid Sink” Theory: The primary proposed mechanism is the “lipid sink”. A bolus of 20% lipid emulsion creates an expanded lipid phase in the bloodstream. Lipophilic drug molecules are “pulled” out of target tissues (like the heart and brain) and partitioned into this intravascular lipid sink, reducing the concentration of free drug available to cause toxicity.
• The ILE Protocol: The protocol involves a bolus of 5 mL/kg of 20% lipid emulsion, which can be repeated, followed by a continuous infusion.

Special Considerations in Toxicology

Serotonin Syndrome: Recognition and Stepwise Management

When a patient presents with agitation, tachycardia, hyperthermia, and neuromuscular hyperactivity—especially with a history of SSRIs (e.g., sertraline) plus an agent like St. John’s Wort—I consider serotonin syndrome. Key features include hyperreflexia and clonus, which differentiate it from neuroleptic malignant syndrome (NMS) (which has lead-pipe rigidity). Management includes benzodiazepines, cooling, and in some cases, cyproheptadine, a serotonin receptor antagonist.

Sulfonylurea-Induced Hypoglycemia: Octreotide as a Pancreatic Brake

Sulfonylureas stimulate insulin release and can cause profound, prolonged hypoglycemia. Refractory hypoglycemia often requires octreotide, a somatostatin analog that suppresses insulin secretion, in addition to dextrose infusions. These patients require admission for observation.

Anticoagulation Reversal: Practical Algorithms

When bleeding or overdose occurs, reversal must be nuanced:

• Heparin: Reversed by protamine sulfate.
• Warfarin: Vitamin K plus four-factor PCC (prothrombin complex concentrate).
• Dabigatran: Idarucizumab (Praxbind®).
• Rivaroxaban and Apixaban: Andexanet alfa (Andexxa®).

Vasopressor Extravasation: Local Reversal

Peripheral infusion of vasopressors risks extravasation, leading to local ischemia. Our protocol involves stopping the infusion, administering phentolamine (an alpha-adrenergic antagonist) through the infiltrated line and into surrounding tissues to counteract vasoconstriction, and applying warm compresses.

Poison Control: A National Collaboration in Real Time

I remind patients and clinicians: Poison Control (1-800-222-1222 in the US) offers universal access to toxicology expertise. We coordinate with them to ensure timely interventions and consistent best practices.

Conclusion: The Integrated Path to Recovery

Our exploration of toxicology has taken us from the fundamental principles of decontamination and the ABCs to the intricate physiological battles at the cellular level. The management of an acute poisoning demands rapid assessment and a firm grasp of emergency and critical care principles, the domain where the medical expertise of physicians like Dr. Cardenas is essential.

However, the patient’s journey does not end upon discharge. The aftermath of a toxic exposure can leave a lasting imprint. This is where the true power of our integrative model at Injury Medical Clinic PA shines.

• Restoring Neurological and Autonomic Balance: The nervous system bears the brunt of many toxic insults. Chiropractic care plays a vital role in restoring proper neurological function and autonomic balance. By addressing spinal subluxations and improving nerve flow, we help the body’s master control system recalibrate.
• Supporting Metabolic Detoxification and Mitochondrial Health: A toxic insult places an immense burden on the body’s detoxification systems. Our functional medicine approach allows us to assess these pathways and provide targeted support through nutritional strategies and supplements (like milk thistle, N-acetylcysteine, B vitamins, CoQ10, and L-carnitine) to help the body clear residual toxins and repair cellular damage.
• Rebuilding from the Ground Up: Many poisonings result in significant nutritional depletion and systemic inflammation. We work with patients to create personalized anti-inflammatory diets and replete essential nutrients, providing the building blocks the body needs to heal.

By seamlessly blending the critical medical management overseen by Dr. Cardenas with the restorative and root-cause-focused therapies of chiropractic and functional medicine that I provide, we offer our patients a truly comprehensive path to recovery. This collaborative, patient-centered approach is the future of healthcare, and we are proud to offer it to the community of El Paso and beyond.

References

• Albanese, J., & Olson, K. R. (2001). Tricyclic antidepressant overdose. Emergency Medicine Clinics of North America, 19(4), 781-794.
• Anker, A., & Varney, S. (2024). Cyanide Poisoning. In StatPearls. StatPearls Publishing.
• Birmes, P., Coppin, D., Schmitt, L., & Lauque, D. (2003). Serotonin syndrome: a brief review. Intensive Care Medicine, 29(7), 1032–1038.
• Boehnhert, M. T., & Lovejoy, F. H. (1985). Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. The New England Journal of Medicine, 313(8), 474–479.
• Boyer, E. W. (2012). Management of opioid analgesic overdose. The New England Journal of Medicine, 367(2), 146–155.
• Boyer, E. W., & Shannon, M. (2005). The serotonin syndrome. New England Journal of Medicine, 352(11), 1112–1120.
• Bronstein, A. C., Spyker, D. A., Cantilena, L. R., Rumack, B. H., & Dart, R. C. (2015). 2014 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 32nd Annual Report. Clinical Toxicology, 53(10), 962–1147.
• Chin, S. B., & Duffy, L. (2015). Salicylate toxicity. Drugs & Aging, 32(4), 323–329.
• Chyka, P. A., & Seger, D. (1997). Position statement: Single-dose activated charcoal. American Journal of Emergency Medicine, 15(5), 455–461.
• Chyka, P. A., Seger, D., Krenzelok, E. P., & Vale, J. A. (2005). Position paper: Single-dose activated charcoal. Academic Emergency Medicine, 12(4), 391–396.
• Connolly, S. J., Milling Jr., T. J., Eikelboom, J. W., et al. (2016). Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. New England Journal of Medicine, 375(12), 1131–1141.
• Dart, R. C., Rumack, B. H., & Erdman, A. R. (2006). Acetaminophen poisoning: an evidence-based consensus guideline. Clinical Therapeutics, 28(5), 527–540.
• DeLima, G., et al. (2010). Whole bowel irrigation for overdose management. Clinical Toxicology, 48(5), 436–444.
• Engebretsen, K. M., Kaczmarek, K. M., Morgan, J., & Holger, J. S. (2011). High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clinical Toxicology, 49(4), 277–283.
• Erdman, A. R. (2004). Salicylate toxicity. Emergency Medicine Clinics of North America, 22(4), 915–928.
• Glatstein, M., et al. (2012). Octreotide for the treatment of sulfonylurea-induced hypoglycemia. The American Journal of the Medical Sciences, 344(3), 223-227.
• Greene, S. L., & Dargan, P. I. (2012). High-dose insulin euglycemia for the management of cardiotoxic drug overdose. Toxicological Reviews, 21(3), 241–250.
• Hampson, N. B., & Weaver, L. K. (2017). Carbon monoxide poisoning: A new standard of care. Undersea & Hyperbaric Medicine, 44(2), 91–95.
• Harte, S. E., et al. (2012). The neurobiology of chiropractic modulation of pain. Journal of Manipulative and Physiological Therapeutics, 35(9), 692–703.
• Hoffman, J. R., Schriger, D. L., et al. (1997). Sodium bicarbonate efficacy in tricyclic overdose. Annals of Emergency Medicine, 30(5), 546–553.
• Hojer, J., Troutman, W. G., et al. (1990). Flumazenil risks in benzodiazepine overdose. QJM: An International Journal of Medicine, 77(2), 207–219.
• Juurlink, D. N., & Fralick, M. (2019). Salicylate Toxicity. New England Journal of Medicine, 381(8), e16.
• Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., et al. (2009). Hyperglycemic crises in adult patients with diabetes. Diabetes Care, 32(7), 1335–1343.
• Kraut, J. A., & Madias, N. E. (2018). Metabolic acidosis: pathophysiology, diagnosis, and management. New England Journal of Medicine, 378(15), 1419–1431.
• Lange, R. A., & Hillis, L. D. (2001). Cardiovascular complications of cocaine use. The New England Journal of Medicine, 345(5), 351–358.
• Lee, J., & Gardiner, A. (2012). Iron poisoning treated with deferoxamine. BMJ Case Reports, 2012, bcr0120125570.
• Levine, M. (2015). Salicylate toxicity management updates. Emergency Medicine Clinics of North America, 33(2), 333–351.
• Levine, M., & Ruha, A. M. (2012). Anticholinergic poisoning. Emergency Medicine Clinics of North America, 30(2), 329–343.
• Levine, M., Ruha, A. M., Wolk, B. S., Caravati, M., Brent, J., & Campleman, S. (2017). The Toxicology Investigators Consortium (ToxIC) Registry. Journal of Medical Toxicology, 13(4), 289–292.
• Lott, C., Truhlář, A., Alfonzo, A., Barelli, A., González-Salvado, V., Hatanpää, T., … & Deakin, C. D. (2021). European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances. Resuscitation, 161, 152–219.
• Lynn, P., & Curry, K. (2011). Vasopressor extravasation management with phentolamine. Journal of Cardiovascular Nursing, 26(5), E28–E32.
• McMartin, K., Jacobsen, D., & Hovda, K. E. (2016). Antidotes for poisoning by alcohols that form toxic metabolites. British Journal of Clinical Pharmacology, 81(3), 505–515.
• Morin, C., He, T., Kahlon, J., Ayas, N., & Bshouty, Z. (2016). Xylazine-induced skin ulcers in a person who injects drugs in Canada. CMAJ, 188(17-18), E554.
• Mowry, J. B., Spyker, D. A., Brooks, D. E., McMillan, N., & Schauben, J. L. (2016). 2015 Annual Report of the American Association of Poison Control CCenters’National Poison Data System (NPDS): 33rd Annual Report. Clinical Toxicology, 54(10), 924–1109.
• Navid, H., et al. (2020). Autonomic effects of manual therapy. Chiropractic & Manual Therapies, 28, 26.
• Nelson, L. S., Howland, M. A., Lewin, N. A., Smith, S. W., Goldfrank, L. R., & Hoffman, R. S. (Eds.). (2019). Goldfrank’s Toxicologic Emergencies (11th ed.). McGraw-Hill Education.
• O’Malley, G. F. (2007). Emergency department management of the salicylate-poisoned patient. Emergency Medicine Clinics of North America, 25(2), 333–346.
• Penninga, E., et al. (2016). Flumazenil for benzodiazepine overdose. Cochrane Database of Systematic Reviews, CD004987.
• Peter, J. V., & Sudarsan, T. I. (2007). Choice of atropine dose in organophosphate and carbamate poisoning. Critical Care, 11(2), R36.
• Pollack, C. V., Reilly, P. A., van Ryn, J., et al. (2015). Idarucizumab for dabigatran reversal. New England Journal of Medicine, 373(6), 511–520.
• Reich, B. N., et al. (2010). Extravasation injury and management. Journal of Infusion Nursing, 33(6), 392- 398.
• Richards, J. R., Albertson, T. E., Derlet, R. W., Lange, R. A., Olson, K. R., & Horowitz, B. Z. (2015). Treatment of toxicity from synthetic cathinones”bath salts”. The Journal of Emergency Medicine, 49(4), 487-494.
• Rose, B. D., & Post, T. W. (2023). Clinical Physiology of Acid-Base and Electrolyte Disorders (6th ed.). McGraw-Hill Education.
• Rumack, B. H. (2002). Acetaminophen hepatotoxicity: the first 35 years. Clinical Toxicology, 40(1), 3–20.
• Rumack, B. H., & Matthew, H. (1975). Acetaminophen poisoning and toxicity. The Lancet, 305(7903), 519–522.
• Salhanick, S., & Shannon, M. (2003). Toxicological emergencies and ventilation. Annals of Emergency Medicine, 41(6), 857–861.
• Sarode, R., et al. (2013). PCC vs plasma for warfarin reversal. New England Journal of Medicine, 368(13), 1237–1241.
• Seger, D. L. (2004). Clonidine. In Medical Toxicology (3rd ed., pp. 679-688). Lippincott Williams & Wilkins.
• Spiller, H. A., et al. (1997). Octreotide in sulfonylurea-induced hypoglycemia. Journal of Emergency Medicine, 15(5), 687–692.
• Weaver, L. K. (2009). Carbon Monoxide Poisoning. New England Journal of Medicine, 360(12), 1217–1225.
• Weinberg, G. L. (2012). Lipid emulsion infusion: resuscitation for local anesthetic and other drug overdose. Anesthesiology, 117(1), 180–187.
• Wolfsdorf, J. I., et al. (2018). ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatric Diabetes, 19(Suppl. 27), 155–177.
• Yoon, E., et al. (2016). Acetaminophen toxicity: current strategies. Chest, 149(2), 356–367.

SEO Tags: Toxicology, Integrative Medicine, Chiropractic Care, Functional Medicine, Anticholinergic Toxidrome, Cholinergic Crisis, Sympathomimetic Overdose, Opioid Overdose, Naloxone, Acetaminophen Toxicity, Salicylate Poisoning, High-Dose Insulin Therapy, Intravenous Lipid Emulsion, Dr. Alex Jimenez, Dr. Maria Cardenas, El Paso TX, Personal Injury, Decontamination, Poison Management, Tricyclic Antidepressant Overdose, Organophosphate Poisoning, Cocaine Toxicity, Sodium Channel Blockade, Acetylcholinesterase, N-Acetylcysteine, Rumack-Matthew Nomogram, Autonomic Nervous System, HPA Axis Dysfunction, Metabolic Detoxification, clonidine overdose, xylazine, tranq, beta-blocker overdose, calcium channel blocker overdose, toxic alcohols, ethylene glycol, methanol, anion gap, osmolar gap, naloxone uses, ROCK LOTA X, HIE therapy, lipid sink, Cyanide Poisoning, Carbon Monoxide Poisoning, Inhalation Injury, Toxidrome, Hydroxocobalamin, Carboxyhemoglobin, Hyperbaric Oxygen Therapy, Metabolic Acidosis, Oxidative Phosphorylation, Neurological Rehabilitation, Mitochondrial Health, integrative toxicology, serotonin syndrome, sulfonylurea hypoglycemia, octreotide, anticoagulant reversal, protamine, PCC, andexanet alfa, idarucizumab, benzodiazepine overdose, flumazenil caution, iron poisoning, deferoxamine, vasopressor extravasation, phentolamine, whole bowel irrigation